Aluminium hydroxide-induced granulomas in pigs. 2005

S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
DVM, Azienda Agricola Floria,Via Piave, Orzivecchi, Brescia, Italy. serafinovaltu@aliceposta.it

The effect of intramuscular injection of 40 mg/2 ml aluminium hydroxide in the neck of pigs was examined in a number of ways. The investigation followed repeated slaughterhouse reports, according to which 64.8% of pigs from one particular farm were found at slaughter to have one or more nodules in the muscles of the neck (group slaughtered). The pigs had been injected with a vaccine containing 40 mg/2 ml dose of aluminium hydroxide as adjuvant. Research consisted of two phases: first, an epidemiological study was carried out, aimed at determining the risk factors for the granulomas. The results indicated that the vaccine was to be held responsible for the formation of granulomas. A clinical trial was then performed to further substantiate the initial hypothesis, by comparing pigs, which were aseptically inoculated twice with either the original vaccine or the adjuvant alone (groups vaccine and adjuvant) to pigs inoculated twice with apyrogenic bi-distilled water (group water) and to pigs inoculated once with the adjuvant and once with apyrogenic bi-distilled water (group adjuvant/water). Both studies agreed in their conclusions, which indicate that the high amount of aluminium hydroxide was the cause of the granulomas.

UI MeSH Term Description Entries
D009333 Neck The part of a human or animal body connecting the HEAD to the rest of the body. Necks
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D004577 Electron Probe Microanalysis Identification and measurement of ELEMENTS and their location based on the fact that X-RAYS emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It is performed with an electron microscope fitted with an x-ray spectrometer, in scanning or transmission mode. Microscopy, Electron, X-Ray Microanalysis,Spectrometry, X-Ray Emission, Electron Microscopic,Spectrometry, X-Ray Emission, Electron Probe,X-Ray Emission Spectrometry, Electron Microscopic,X-Ray Emission Spectrometry, Electron Probe,X-Ray Microanalysis, Electron Microscopic,X-Ray Microanalysis, Electron Probe,Microanalysis, Electron Probe,Spectrometry, X Ray Emission, Electron Microscopic,Spectrometry, X Ray Emission, Electron Probe,X Ray Emission Spectrometry, Electron Microscopic,X Ray Emission Spectrometry, Electron Probe,X-Ray Microanalysis,Electron Probe Microanalyses,Microanalyses, Electron Probe,Microanalysis, X-Ray,Probe Microanalyses, Electron,Probe Microanalysis, Electron,X Ray Microanalysis,X Ray Microanalysis, Electron Microscopic,X Ray Microanalysis, Electron Probe
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27
D000536 Aluminum Hydroxide A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. Hydrated Alumina,Aldrox,Algeldrate,Alhydrogel,Alugel,Amphojel,Basalgel,Brasivil,Dialume,Nephrox,Pepsamer,Rocgel,Alumina, Hydrated,Hydroxide, Aluminum
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013054 Spectrophotometry, Atomic Spectrophotometric techniques by which the absorption or emmision spectra of radiation from atoms are produced and analyzed. Spectrophotometry, Atomic Absorption,AA Spectrophotometry,AE Spectrophotometry,Atomic Absorption Spectrophotometry,Atomic Emission Spectrophotometry,Atomic Spectrophotometry,Inductively Coupled Plasma Atomic Emission Spectrophotometry,Inductively Coupled Plasma Atomic Emission Spectroscopy,Spectrophotometry, Atomic Emission,AA Spectrophotometries,AE Spectrophotometries,Absorption Spectrophotometry, Atomic,Emission Spectrophotometry, Atomic,Spectrophotometries, AA,Spectrophotometries, AE,Spectrophotometry, AA,Spectrophotometry, AE
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
July 1982, The British journal of dermatology,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
September 1971, British medical journal,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
September 2000, Allergy,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
March 2014, Ugeskrift for laeger,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
April 2015, Ugeskrift for laeger,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
September 2021, Veterinary medicine and science,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
January 1994, Acta veterinaria Scandinavica,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
March 2022, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
October 1973, Proceedings of the Royal Society of Medicine,
S Valtulini, and C Macchi, and P Ballanti, and Y Cherel, and A Laval, and J M Theaker, and M Bak, and E Ferretti, and H Morvan
December 1972, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!